Tiger Biosciences

Biotechnology Company

Based in PA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $860K in lobbying spend across 10 quarterly filings, Tiger Biosciences is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2024 to 2025.

$860K
Total Spend
2
Years Active
1
Firms Hired
6
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2024$290K
2025$570K

Issues Lobbied

MEDMedicare/Medicaid

Lobbying Firms

Ballard Partners

Lobbyists

Daniel McfaulMichael LarosaTola ThompsonBrian BallardGerald John O'hanlonBridget Nocco

Government Agencies Targeted

These are the government entities that Tiger Biosciences disclosed contacting in their lobbying filings.

Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESSENATECenters For Medicare and Medicaid Services (CMS)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED, Medicare/Medicaid

Promoting the advancement of healthcare technology.

Guidance and advocacy related to Medicare coverage.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Drexel University
$3.4M total spend
University of Pennsylvania Perelman School of Medicine
$1.0M total spend
Amerihealth Caritas
$720K total spend
Association for Frontotemporal Degeneration
$180K total spend
Pacific Edge Diagnostics USA
$60K total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.